Micelles self-assembled from poly(ethylene oxide)-block-poly(N-hexyl stearate L-aspartamide) by a solvent evaporation method:: effect on the solubilization and haemolytic activity of amphotericin B

被引:110
作者
Lavasanifar, A
Samuel, J
Kwon, GS
机构
[1] Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA
[2] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada
关键词
block copolymer micelles; drug delivery; haemolysis; amphotericin B;
D O I
10.1016/S0168-3659(01)00477-1
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The goal of this study was to assess a solvent evaporation method for the encapsulation of amphotericin B (AmB) in poly(ethylene oxide)-block-poly(N-hexyl stearate L-aspartamide) (PEO-b-PHSA) micelles. By the solvent evaporation method, PEO-b-PHSA self-assembled into small spherical micelles with a high AmB content based on transmission electron microscopy, size exclusion chromatography and absorption spectroscopy. The encapsulation of AmB was slightly better than an earlier method based on dialysis. Importantly, AmB in PEO-b-PHSA micelles encapsulated by the solvent evaporation method was non-haemolytic at 15 mug/ml, whereas AmB in PEO-b-PHSA micelles encapsulated by the dialysis method caused 50% haemolysis at the level of 3.8 mug/ml, and AmB itself caused 100% haemolysis at 1.0 mug/ml. Thus, PEO-b-PHSA micelles could effectively encapsulate AmB, increase the overall water solubility of AmB and reduce the toxicity of the membrane-acting drug, particularly by a solvent evaporation method. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:155 / 160
页数:6
相关论文
共 11 条
[1]  
Brajtburg J, 1996, CLIN MICROBIOL REV, V9, P512, DOI 10.1128/CMR.9.4.512
[2]   TOXICITY OF SOLUBILIZED AND COLLOIDAL AMPHOTERICIN-B FORMULATIONS TO HUMAN-ERYTHROCYTES [J].
FORSTER, D ;
WASHINGTON, C ;
DAVIS, SS .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1988, 40 (05) :325-328
[3]   Doxorubicin-loaded poly(ethylene glycol)-poly(β-benzyl-l-aspartate) copolymer micelles:: their pharmaceutical characteristics and biological significance [J].
Kataoka, K ;
Matsumoto, T ;
Yokoyama, M ;
Okano, T ;
Sakurai, Y ;
Fukushima, S ;
Okamoto, K ;
Kwon, GS .
JOURNAL OF CONTROLLED RELEASE, 2000, 64 (1-3) :143-153
[4]   BLOCK-COPOLYMER MICELLES AS VEHICLES FOR HYDROPHOBIC DRUGS [J].
KWON, GS ;
NAITO, M ;
KATAOKA, K ;
YOKOYAMA, M ;
SAKURAI, Y ;
OKANO, T .
COLLOIDS AND SURFACES B-BIOINTERFACES, 1994, 2 (04) :429-434
[5]   The effect of alkyl core structure on micellar properties of poly(ethylene oxide)-block-poly(L-aspartamide) derivatives [J].
Lavasanifar, A ;
Samuel, J ;
Kwon, GS .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2001, 22 (02) :115-126
[6]  
Lavasanifar A, 2000, J BIOMED MATER RES, V52, P831, DOI 10.1002/1097-4636(20001215)52:4<831::AID-JBM29>3.0.CO
[7]  
2-K
[8]   Methotrexate esters of poly(ethylene oxide)-block-poly(2-hydroxyethyl-L-aspartamide).: Part I:: Effects of the level of methotrexate conjugation on the stability of micelles and on drug release [J].
Li, Y ;
Kwon, GS .
PHARMACEUTICAL RESEARCH, 2000, 17 (05) :607-611
[9]   Micelle-like structures of poly(ethylene oxide)-block-poly(2-hydroxyetbyl aspartamide)-methotrexate conjugates [J].
Li, Y ;
Kwon, GS .
COLLOIDS AND SURFACES B-BIOINTERFACES, 1999, 16 (1-4) :217-226
[10]   Incorporation of water-insoluble anticancer drug into polymeric micelles and control of their particle size [J].
Yokoyama, M ;
Satoh, A ;
Sakurai, Y ;
Okano, T ;
Matsumura, Y ;
Kakizoe, T ;
Kataoka, K .
JOURNAL OF CONTROLLED RELEASE, 1998, 55 (2-3) :219-229